Markets
Kalshi seeks CFTC approval for margin trading on event contracts
Prediction market platform Kalshi files with CFTC to allow leverage on event contracts, aiming to attract institutional investors. The move follows similar efforts by rival Polymarket.
Binance invests $100M in Circle under expanded USDC deal
Crypto exchange Binance has invested $100 million in stablecoin issuer Circle as part of a five-year agreement to promote USDC on its platform.
Reap to launch Mexican peso stablecoin and explore other local‑currency tokens for 24/7 FX settlement
Fintech Reap, backed by Payward and partnered with Visa, plans a peso‑linked stablecoin and is evaluating Hong Kong dollar, euro, won and yen tokens to enable round‑the‑clock cross‑border foreign‑exchange.
FDA Relaxes Hold on Filana’s Simufilam TSC Trial
Phase 2a study targets refractory epilepsy in tuberous sclerosis complex, with 40 patients to enroll by Q1 2027
Valion Bio regains Nasdaq $1 bid price compliance
Valion Bio received written notice from Nasdaq confirming it met the $1 minimum bid price requirement after its shares closed at $2.38, up 12.26%, on Sep 21.
China Approves Adagene's IND for ADG138 Cancer Drug
Adagene cleared to launch Phase 1 trials of its ADG138 bispecific in China, with dosing planned for late 2026 in advanced solid tumors.
Enlivex Ends $200M+ Private Placement After Rain Foundation Deal Termination
Enlivex Ltd. (ENLV) halted a planned $66.7M share sale to Rain Foundation, citing shareholder approval failure and exercising termination rights under the agreement.
Euro falls to $1.145 as oil rises and German political turmoil weighs
The euro slipped to $1.145, its lowest since late July, amid higher Brent crude prices and mounting political risk after the CDU’s defeats in German state elections.
Scynexis Names Former Akebia Chief Medical Officer to Its Board
The clinical-stage biotech has added Steven K. Burke, currently SVP and chief research and development officer at Akebia Therapeutics, to its board of directors effective Sept. 18.
PDS Biotech Reports 39.3-Month Median Survival in HPV16 Head-and-Neck Cancer Trial
The Phase 2 VERSATILE-002 study showed a median overall survival of 39.3 months for patients with HPV16-positive recurrent or metastatic head and neck squamous cell carcinoma who were naïve to checkpoint inhibitors and had PD-L1 CPS ≥1. The combination of PDS0101 and pembrolizumab yielded an objective response rate of 36% with a manageable safety profile.
Electra AI signs multiple commercial deals ahead of Nasdaq listing
Electra AI, valued at about $250 million, announced a series of partnerships with D‑Orbit, Naoris Quantum, Propel Industries, Omega Seiki, MinTech and Mooving as it prepares for a Nasdaq debut via a SPAC merger with Iron Horse Acquisition II.
Oil prices turn negative amid market shifts as crude prices drop
Oil prices moved into negative territory as crude prices fell, affecting global energy benchmarks.
China gold imports surpass 1,000 tonnes, set new annual record
Chinese gold imports topped 1,000 tonnes by August, already exceeding the full-year 2025 total, as a stronger yuan and central bank buying fuel demand.
CNSide Diagnostics signs in‑network agreement with Blue Cross Blue Shield of Michigan
CNSide Diagnostics, a Cerenome subsidiary, will provide its CSF tumor cell assay to Blue Cross Blue Shield of Michigan, expanding coverage to about 158 million lives.
ECB and EU central banks oppose stablecoin bank deposit reserve requirements
Finance Review Daily is tracking this developing story; finance review daily will provide updates as verified details become available.
US-Märkte vor Eröffnung ohne klare Richtung: SMI gedämpft, UBS unter Druck
Schweizer Aktienindex leidet unter globaler Unsicherheit; UBS fällt unter Regulierungsfragen, während On-Aktien durch Wachstumsprognosen und Rückkaufprogramm unterstützt werden.
Beta Bionics and Senseonics Partner on Glucose Monitoring Integration
Beta Bionics Inc. and Senseonics have partnered to integrate their automated insulin delivery systems with the Eversense 365 continuous glucose monitoring system, expected to launch in Q4 2026.
Greenbrier Secures $600M Railcar Order from Saudi Railway
The Greenbrier Companies secured 3,400 railcar orders valued at $600 million, including a significant Saudi Railway deal for tank cars and intermodal units.
Borsa Istanbul to drop over a quarter of BIST-100 constituents
More than 25% of the stocks currently in Turkey's BIST-100 benchmark will be removed next month as the exchange tightens eligibility rules, without citing a specific trigger.
CollPlant Regains Nasdaq Compliance After Share Price Dips Below $1
The Rehovot-based biotech firm restored its Nasdaq listing after its shares closed at or above the $1 minimum for 10 consecutive business days.
Canopy Growth to supply UK with four Canadian-grown medical cannabis strains
Canopy Growth Corporation will supply four strains of Canadian-grown medical cannabis to the UK market through its Spectrum Therapeutics brand, following renewed EU certification at its Kincardine facility.
Arrive AI to Showcase Autonomous Delivery Tech at Investor Event
The Indiana-based logistics firm will demonstrate its Arrive Point network, AMR handoff system, and simulated drone deliveries during a virtual investor event Wednesday.
Kazia Secures $2M Milestone as Paxalisib Epilepsy Trial Begins
Kazia Therapeutics advances its paxalisib program with a $2M milestone payment as a Phase 1b/2a trial targets intractable epilepsy linked to rare mTORopathies.
Wave Life Sciences appoints Monika Vnuk as chief business officer
Wave Life Sciences has appointed Monika Vnuk to the role of chief business officer.
Lantern Pharma Secures Patent for LP-284 Cancer Drug
USPTO grants Notice of Allowance for LP-284, targeting mantle cell lymphoma and double-hit lymphoma, with broader claims covering combination therapies and a 2042 patent expiry.